Related Experiment Video
Updated: Jul 8, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Synthetic approaches to the 2006 new drugs
Kevin K-C Liu1, Subas M Sakya, Jin Li
1Pfizer Inc, La Jolla, CA 92037, USA. Kevin.k.liu@pfizer.com
Abstract:
New drugs are introduced to the market every year and each individual drug represents a privileged structure for its biological target. In addition, these new chemical entities (NCEs) not only provide insights into molecular recognition, but also serve as drug-like leads for designing future new drugs. To these ends, this review covers the syntheses of 16 NCEs marketed in 2006.
Related Concept Videos
Drug Discovery: Overview
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Drug Regulation
Drug Nomenclature
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Clinically Relevant Drug Product Specifications: Methods of Establishment

